LabCompass

Paul A. Sobotka

Medicine · The Ohio State University

Established · publishing since 1981Rising activity

Publications

183

Citations

9,299

Est. group size

Recurring co-author estimate

Active years

45

Publishing since 1981

Research summary
AI-generated

Paul A. Sobotka's work focuses on hypertension and heart failure, particularly device-based and physiology-guided approaches to treatment. His research covers renal nerve ablation (denervation) for high blood pressure, hemodynamic (blood flow and pressure)-guided drug therapy, and catheter-based interventions such as splanchnic nerve modulation and arteriovenous anastomosis for managing heart failure and blood pressure. This research would suit students interested in clinical trials and interventional approaches to cardiovascular disease.

Hypertension management and blood pressure controlRenal denervation and catheter-based interventionsHeart failure treatment and hemodynamicsPrecision medicine approaches to cardiovascular diseaseClinical trial design and methodology

Publication output has been fairly steady but modest over the last decade, fluctuating between 1 and 5 papers per year without a clear upward or downward trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
2017: 2 publications172018: 5 publications5182019: 2 publications192020: 1 publication202021: 3 publications212022: 2 publications222023: 4 publications232024: 3 publications242025: 1 publication2526
Recent publications
Publishes in
  • European Heart Journal×3
  • Journal of Cardiovascular Translational Research×3
  • Journal of Hypertension×3
  • European Journal of Heart Failure×2
  • Journal of the American Heart Association×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile